Hospital Psychiatry - Articles - Page 12

Melatonin vs Memantine for ECT-Related Cognitive Impairment

September 13, 2021

Anne Li, MD. Dr. Li has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Memantine appears more effective than melatonin in reducing post-ECT cognitive impairment.

Faster Refeeding of Patients With Anorexia Nervosa Appears Safe

September 13, 2021

Susie Morris, MD.

Susie Morris, MD. Dr. Morris has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Higher calorie refeeding of patients with anorexia nervosa appears no less safe than low calorie refeeding and leads to quicker stabilization.

Can We Treat Depression by Targeting Inflammation?

September 13, 2021

Christina Guest, MD.

Christina Guest, MD. Dr. Guest has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

If inflammation plays a role in mood, it makes sense to explore the effects of antibiotics on depression. This study does just that.

IM Olanzapine Plus Benzodiazepines: Safe or Unsafe?

September 13, 2021

Daniel Carlat, MD

Victoria Hendrick, MD. Editor in Chief, The Carlat Hospital Psychiatry Report. Chief, Inpatient Psychiatry, Olive View UCLA Medical Center.

Daniel Carlat, MD. Publisher, The Carlat Hospital Psychiatry Report.

Dr. Hendrick and Dr. Carlat have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

If you have ever tried to electronically prescribe IM olanzapine with an IM/IV/subcutaneous benzodiazepine, you have probably received an interaction alert warning about the potential for excessive sedation and cardiorespiratory depression. Is this warning justified? Let’s look at the data.

Note From the Editor-in-Chief

September 13, 2021

Victoria Hendrick, MD. Editor in Chief, The Carlat Hospital Psychiatry Report. Chief, Inpatient Psychiatry, Olive View UCLA Medical Center. Dr. Hendrick has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Sometimes we have little choice but to administer sedating medications to a combative patient who is putting others at risk of injury. Which medications work most quickly, safely, and effectively?

Learning Objectives, Agitation, CHPR, October/November/December 2021

September 13, 2021

After reading these articles, you should be able to…

CME Post-Test - Agitation, CHPR, October-November-December 2021

September 13, 2021

The post-test for this issue is available for one year after the publication date to subscribers. By successfully completing the test you will be awarded a certificate for 2 CME credits.

Battle of the Bulge: Obesity and Antipsychotic-Induced Weight Gain

July 14, 2021

Farah Khorassani, PharmD. Clinical Assistant

Farah Khorassani, PharmD. Clinical Assistant Professor of Pharmacy Practice, St. John’s University, Queens, NY. Dr. Khorassani has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

With so many weight loss medications on the market, it’s hard to know which to choose. Dr. Khorassani tells us everything we need to know to about selecting and prescribing these agents. Also, she gives us additional tips for managing antipsychotic-induced weight gain.

Weight Gain and Metabolic Side Effects

July 14, 2021

Stephen Marder, MD

Stephen Marder, MD

Daniel X. Freedman Professor of Psychiatry. Vice Chair for Education, Semel Institute for Neuroscience at UCLA. Director, VA VISN 22 Mental Illness Research, Education, and Clinical Center, San Diego, CA.

Dr. Marder has disclosed no relevant financial or other interests in any commercial companies pertaining to educational activity.

Dr. Steve Marder describes interventions to minimize patients’ antipsychotic-induced weight gain and insulin resistance.